Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
03/2001
03/27/2001US6207134 Ultrafine lightly coated superparamagnetic particles for MRI
03/22/2001WO2001019838A1 Macrocyclic chelants for metallopharmaceuticals
03/22/2001WO2001019799A2 Nitroimidazole derivative and diagnostic imaging agent containing the same
03/22/2001WO2001019456A1 Radioactive brachytherapy source and material and manufacturing method therefore
03/22/2001WO2000057924A3 Colloid for scintigraphy
03/22/2001DE19951715C1 New 18-fluoro-labeled cytosine derivatives, useful as tracers for monitoring activity of transferred cytosine deaminase genes in gene therapy of tumors
03/22/2001CA2382057A1 Macrocyclic chelants for metallopharmaceuticals
03/21/2001EP1084733A1 Radiation source for endovascular radiation treatment in form of a wire
03/21/2001EP1084145A2 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use thereof for diagnosis and therapy of tumors and diseases associated with angiogenesis
03/21/2001EP1083938A2 Patient-specific dosimetry
03/21/2001EP1083937A1 Radioioinated phenols for brachytherapy
03/21/2001EP1083920A1 Novel antibacterial compounds
03/21/2001EP1083919A1 Novel antiviral compounds
03/21/2001EP1083918A1 Novel therapeutic agents that modulate 5-ht receptors
03/21/2001CN1288469A Monoclonal antibody anti alpha; V-integrin and it use to inhibit & alpha; V & beta; 6-integrain attachment to fibronectine
03/21/2001CN1063344C Medical box for labelling pingyangmycin for tumer positive developing agent
03/20/2001US6204296 Patient oxygenation using stabilized fluorocarbon emulsions
03/20/2001US6204248 Pharmaceutical preparations of glutathione and methods of administration thereof
03/20/2001US6203777 Method of contrast enhanced magnetic resonance imaging using carbohydrate particles
03/15/2001WO2001018011A1 Calcium complex of phosphorus containing ethylenediamine derivatives
03/15/2001WO2001018006A1 Inhibitors of prenyl-protein transferase
03/15/2001WO2001017569A2 Improved container composition for radiopharmaceutical agents
03/15/2001WO2001017567A2 Improved container composition for diagnostic agents
03/15/2001WO2001017566A2 L-selectin contrast agents
03/15/2001CA2384151A1 Inhibitors of prenyl-protein transferase
03/13/2001US6200763 Detecting cell expressing myeloid polypeptide; incubate cell with binding substance and detecting bound substance, presence of bound protein indicates cell expressing myeloid protein
03/13/2001US6200547 Carrier including particles that include iron and carbon; therapeutic amount of doxorubicin or paclitaxel adsorbed on the particles.
03/13/2001US6200546 Gastrin receptor-avid peptide conjugates
03/08/2001WO2001016103A1 Fused pyrrolecarboxamides: gaba brain receptor ligands
03/08/2001WO2001015746A1 Radiopharmaceutical products and their preparation procedure
03/08/2001WO2000006243A3 Absorbable brachytherapy and chemotherapy delivery devices and methods
03/08/2001WO1999064047A8 Novel antiviral compounds
03/08/2001CA2383517A1 Radiopharmaceutical products and their preparation procedure
03/08/2001CA2381553A1 Fused pyrrolecarboxamides: gaba brain receptor ligands
03/07/2001EP1081147A2 Substituted nortropanes and their use as imaging agents for neurodegenerative disorders
03/07/2001EP1080369A1 Multi-partite ligands and methods of identifying and using same
03/07/2001EP1080202A2 Convection-enhanced delivery of aav vectors
03/07/2001EP1079866A2 Methods of inhibiting clot formation
03/07/2001EP1079862A1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
03/07/2001EP1079833A1 Cocaine receptor binding ligands
03/07/2001CN1286122A Radioactive Re labelled glucosan medicines and preparing process thereof
03/06/2001US6197278 Method of imaging cell death in vivo
03/06/2001CA1341198C Monoclonal antibodies against melanoma-associated antigens, hybrid cell lines producing these antibodies, and use therefor
03/01/2001WO2001014354A1 Substituted 2-arylbenzazole compounds and their use as antitumour agents
03/01/2001WO2001014011A1 Multi layer radiation delivery balloon
03/01/2001WO2001013949A2 Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases
03/01/2001WO2001013893A2 Use of simple amino acids to form porous particles
03/01/2001WO2000052031A3 Kit for radiolabeling proteins with yttrium-90
03/01/2001WO2000032240B1 Radioconjugation of internalizing antibodies
02/2001
02/28/2001EP1077998A1 Labelled glutamine and lysine analogues
02/28/2001EP1077729A2 Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
02/28/2001CN1062566C Nuclide marked immunoglobulin M monoantibody segment
02/27/2001US6194386 Labelled peptide compounds
02/27/2001US6193970 Potentiating local inflammatory or immune response to administration of tumor antigen in mammalian subject by administering tumor antigen in form of tumor cells, or subcellular antigenic material and cytokine or cytokines
02/27/2001US6193950 For diagnosis and therapy
02/27/2001CA2066031C Methods for reducing non-target retention of immunoconjugates and metabolites thereof
02/22/2001WO2001013112A1 Melanocortin metallopeptide constructs, combinatorial libraries and applications
02/22/2001WO2001012674A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
02/22/2001WO2001012575A1 Methods for preparing perfluorinated [18f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection
02/22/2001WO2001012234A1 Gene transfer imaging and uses thereof
02/22/2001WO2000062808A3 Cobalamin conjugates useful as antitumor agents
02/22/2001WO2000057787A3 Method for localization of blood clots
02/22/2001WO2000055633A3 Methods of screening for colorectal cancer modulators
02/22/2001DE19940220A1 Preparation for treating rheumatic joint diseases, e.g. arthritis, comprising injectable, induction heatable, iron oxide-based magnetic particles including radionuclide and cytotoxic agent
02/22/2001CA2381706A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
02/22/2001CA2379647A1 Melanocortin metallopeptide constructs, combinatorial libraries and applications
02/22/2001CA2378712A1 Methods for preparing perfluorinated [18f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection
02/21/2001EP1077071A1 Labeled drugs and nitroxyl compounds to be used therein
02/21/2001EP0784683B1 Tie-2 ligands, methods of making and uses thereof
02/20/2001US6190640 Administering indium radiolabelled humanized monoclonal antibody or a in radiolabelled binding fragment of a humanized monoclonal antibody which binds to antigen a33 which is presented on surfaces of cells of cancer carcinoma
02/20/2001US6190637 Method for preparing [F-18-]fluoride ion
02/15/2001WO2001010870A1 Transition metal complexes of n,n',n'-trialkyl- cis,cis-1,3,5-triaminocyclohexane and related compositions and methods of synthesis and use
02/15/2001WO2001010866A1 Interleukin-5 inhibiting 6-azauracil derivatives
02/15/2001WO2001010468A2 Drug-carrier complexes and methods of use thereof
02/15/2001WO2001010462A1 Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-cd20 antibodies
02/15/2001WO2001010461A1 New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy
02/15/2001WO2001010460A1 Treatment of intermediate- and high-grade non-hodgkins lymphoma with anti-cd20 antibody
02/15/2001WO2001010429A2 Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions
02/15/2001WO2001010301A1 Paperbased nuclear medical phantom and the method of using such a phantom
02/15/2001CA2380759A1 Interleukin-5 inhibiting 6-azauracil derivatives
02/15/2001CA2378646A1 Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-cd20 antibodies
02/14/2001EP1075654A1 Radiation handling system and set
02/14/2001EP1075287A1 Positron emission tomography using gallium-68 chelates
02/14/2001EP1075286A2 13c glucose breath test for the diagnosis of diabetes
02/14/2001EP1075277A2 Methods for detecting and inhibiting angiogenesis
02/13/2001US6187910 Chelation compounds, radionuclide metal chelate compounds and radiolabeled targeting moieties formed therefrom, and methods of making and using these compounds, complexes and conjugates for diagnostic and therapeutic use
02/13/2001US6187308 Ameliorating an immune response disorder.
02/13/2001US6187286 Tumor imaging agents, methods and kits
02/13/2001US6187284 Reacting a peptide comprising a free thiol group with an 18 f-bound labelling reagent which also has a group that is reactive with thiols.
02/13/2001US6187037 Metal stent containing radioactivatable isotope and method of making same
02/08/2001WO2001009190A2 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus
02/08/2001WO2001009160A1 Nucleic acid ligands to cd40ligand
02/08/2001WO2001009146A1 Radiolabelled bisphosphonates and method
02/08/2001WO2001008660A2 Targeted fiberless radiative effectors
02/08/2001CA2380545A1 Nucleic acid ligands to cd40ligand
02/07/2001EP1073609A2 Bismuth-213 generator and uses thereof
02/07/2001EP1073477A1 Methods for detecting lesions in dense breast tissue using lhrh antagonists
02/07/2001EP1073475A2 Improvements in or relating to diagnostic/therapeutic agents
02/07/2001EP1073449A1 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
02/07/2001EP0720621B1 Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses